When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Central hypothyroidism

Last reviewed: 22 Nov 2024
Last updated: 17 Jan 2023

Summary

Definition

History and exam

Key diagnostic factors

  • weakness
  • fatigue
  • cold intolerance
Full details

Other diagnostic factors

  • decreased memory
  • constipation
  • muscle cramps
  • weight gain
  • depression
  • dry, coarse skin
  • oligomenorrhea/amenorrhea
  • bradycardia
  • reduced body and scalp hair
  • delayed relaxation of deep tendon reflexes
  • hearing impairment
  • impassive facial expression
  • diabetes insipidus (DI)
  • headache
  • diplopia
  • decreased peripheral vision
  • atrophic breasts
  • galactorrhea
  • moon facies
  • buffalo hump
Full details

Risk factors

  • presence of pituitary mass lesions
  • multiple endocrine neoplasia (MEN) type I
  • head and neck irradiation
  • traumatic brain injury (TBI)
  • age between 5-15 years and 45-60 years (craniopharyngiomas)
  • age 20-50 years (prolactinomas)
  • age 40-80 years (nonfunctioning pituitary adenomas)
  • sarcoidosis
  • histiocytosis
  • hemochromatosis
  • Sheehan syndrome (postpartum pituitary necrosis)
  • lymphocytic hypophysitis
  • family history of central hypothyroidism
  • anticonvulsant drugs
Full details

Diagnostic tests

1st tests to order

  • serum free thyroxine (FT4)
  • serum thyroid-stimulating hormone (TSH)
Full details

Tests to consider

  • pituitary MRI
  • head CT
  • serum prolactin (PRL)
  • fasting morning serum cortisol
  • serum testosterone
  • serum gonadotropins
  • genetic analyses
Full details

Treatment algorithm

ONGOING

all patients

Contributors

Authors

Angela M. Leung, MD, MSc

Associate Professor of Medicine

UCLA David Geffen School of Medicine

VA Greater Los Angeles Healthcare System

Los Angeles

CA

Disclosures

AML serves on the board of directors of the American Thyroid Association (ATA); speaks for China Merck; consulted for Vertice Pharma; and received article process charges paid on behalf of IBSA Institut Biochimique for an invited review article.

Acknowledgements

Dr Angela M. Leung would like to gratefully acknowledge Dr Jacqueline Gilbert and Dr Rasa Zarnegar, previous contributors to this topic.

Disclosures

JG and RZ declare that they have no competing interests.

Peer reviewers

James Lee, MD

Assistant Professor

Department of Endocrine Surgery

Columbia University

New York

NY

Disclosures

JL declares that he has no competing interests.

James V. Hennessey, MD

Director of Clinical Endocrinology

Beth Israel Deaconess Medical Center

Boston

MA

Disclosures

JVH declares that he has no competing interests.

Anthony Weetman, MD, DSc, FRCP, FMedSci

Sir Arthur Hall Professor of Medicine/Pro Vice Chancellor

University of Sheffield

Sheffield

UK

Disclosures

AW declares that he has no competing interests.

  • Differentials

    • Primary hypothyroidism
    • Nonthyroidal illness
    • Iodine deficiency
    More Differentials
  • Guidelines

    • Hypothalamic-pituitary and growth disorders in survivors of childhood cancer
    • Guidelines on the diagnosis and management of central hypothyroidism
    More Guidelines
  • Patient information

    Underactive thyroid

    Underactive thyroid: questions to ask your doctor

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer